This is clearly evident by color Doppler in the pre-operative echo that shows almost no forward flow (from the right atrium to the left ventricle) across the small selleck product orifice (Figure 1), in comparison to the post-operative echo, that shows good flow across both orifices (Figure 7). We chose to connect the small orifice to the left atrium rather than just closing it, because the left AV valve alone would have been small for the patient’s body size, especially after closing the “cleft”. AVSD can rarely occur without inter-atrial or inter-ventricular communications. 2 The hallmark of diagnosis would then be the presence of common AV junction with trileaflet left AV valve. Double orifice left AV

valve occurs in AVSD when a tongue of tissue extends between the mural leaflet and one of the LV components of the bridging leaflets. 3 It occurs in about five percent of patients with partial AVSD. 4 This can also rarely occur with the right AV valve. Surgical repair of the left AV valve

involves closure of the cleft in the main orifice leaving the accessory orifice intact, and the bridging tissue should not be divided as it is crucial for valve function. 5 Double orifice left AV valve occurs when the two left valve orifices drain to the same ventricle. But if each orifice drains to a different ventricle, this is called double outlet atrium. 6,7 Double outlet atrium is a quite rare condition. It can be double outlet right atrium or double outlet left atrium, and is generally caused by misaligned atrial or ventricular septae. 8 In some situations, as in our case, this can result in the presence of three AV valves. 8–10 If one AV connection is absent with straddling of the solitary AV valve, the condition will represent uni-atrial but bi-ventricular connection. 11 In conclusion, this was a rare case of AVSD with intact and misaligned atrial and ventricular septae and overriding and straddling of

the right AV valve resulting in double outlet right atrium and double inlet left ventricle; in addition to subaortic membrane. Acknowledgements We thank Professor Robert Anderson for his advice regarding the pathoanatomy.
MiRNAs are a group of Dacomitinib small (18-25 nucleotide-long), non-coding (i.e. not translated to proteins) RNA molecules that have the ability to bind mature mRNA molecules and affect their translation, thus serving as important post-transcriptional modulators of gene expression. MiRNAs are produced through an elaborate molecular mechanism. Initially, the corresponding DNA region (intergenic, intronic or polycistronic) is transcribed to produce hairpin-shaped primary transcripts called pri-miRNAs. 11,12 Pri-miRNAs are appropriately processed by the microprocessor complex (Dorsha nuclease and Pasha protein) inside the nucleus, to generate 70 nucleotide-long miRNAs called pre-miRNAs.